| Data |
Ora |
Fonte |
Titolo |
|---|
| 21/2/2025 | 19:17 | PRNUS | Kuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to.. |
| 21/2/2025 | 12:03 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 21/2/2025 | 03:00 | GLOBE | ACELYRIN Confirms Receipt of Unsolicited Indication of.. |
| 10/2/2025 | 15:11 | PRNUS | Kuehn Law Encourages NVRO, SLRN, TGI, and PTMN Investors to.. |
| 07/2/2025 | 23:00 | EDGAR2 | Form 425 - Prospectuses and communications, business.. |
| 07/2/2025 | 21:22 | PRNUS | ALERT: Rowley Law PLLC is Investigating Proposed Acquisition.. |
| 06/2/2025 | 23:19 | EDGAR2 | Form 8-K - Current report |
| 06/2/2025 | 22:15 | GLOBE | Alumis and ACELYRIN to Merge Creating a Late-Stage Clinical.. |
| 31/1/2025 | 22:26 | EDGAR2 | Form 8-K - Current report |
| 25/1/2025 | 00:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 06/1/2025 | 22:01 | EDGAR2 | Form 8-K - Current report |
| 06/1/2025 | 22:00 | GLOBE | ACELYRIN, INC. Announces Additional Phase 2 Data and Phase 3.. |
| 03/1/2025 | 02:00 | GLOBE | ACELYRIN, INC. to Host Virtual Investor Event to Share new.. |
| 10/12/2024 | 22:34 | EDGAR2 | Form 8-K - Current report |
| 10/12/2024 | 22:30 | GLOBE | ACELYRIN, INC. Announces Topline Results From Phase 2b/3.. |
| 13/11/2024 | 23:26 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
| 13/11/2024 | 22:03 | EDGAR2 | Form 8-K - Current report |
| 13/11/2024 | 22:01 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13/11/2024 | 22:00 | GLOBE | ACELYRIN, INC. Reports Third Quarter 2024 Financial Results.. |
| 08/11/2024 | 20:17 | EDGAR2 | Form SC 13G - Statement of Beneficial Ownership by Certain.. |
| 06/11/2024 | 22:00 | GLOBE | ACELYRIN, INC. to Report Third Quarter 2024 Financial.. |
| 04/11/2024 | 22:11 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 16/10/2024 | 13:00 | GLOBE | ACELYRIN, INC. Forms Scientific and Patient Advisory Board.. |
| 19/9/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Positive Results from Global Phase.. |
| 10/9/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Positive Proof-of-Concept Data From.. |
| 22/8/2024 | 13:00 | GLOBE | ACELYRIN, INC. to Participate in Upcoming Investor.. |
| 13/8/2024 | 22:18 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 13/8/2024 | 22:14 | EDGAR2 | Form 8-K - Current report |
| 13/8/2024 | 22:00 | GLOBE | ACELYRIN, INC. Announces Positive Phase 3 Data for Izokibep.. |
| 06/8/2024 | 22:30 | GLOBE | ACELYRIN, INC. to Report Second Quarter 2024 Financial.. |
| 11/6/2024 | 23:05 | EDGAR2 | Form 8-K - Current report |
| 05/6/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Positive 16-week Data From its.. |
| 29/5/2024 | 13:00 | GLOBE | ACELYRIN, INC. Announces Lonigutamab Phase 1/2.. |
| 28/5/2024 | 23:20 | EDGAR2 | Form 8-K/A - Current report: [Amend] |
| 25/5/2024 | 01:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 25/5/2024 | 01:10 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 25/5/2024 | 01:06 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 18/5/2024 | 01:12 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 18/5/2024 | 01:09 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 18/5/2024 | 01:05 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
| 14/5/2024 | 22:22 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 09/5/2024 | 14:14 | EDGAR2 | Form DEFA14A - Additional definitive proxy soliciting.. |
| 09/5/2024 | 14:13 | EDGAR2 | Form 8-K - Current report |
| 09/5/2024 | 14:01 | GLOBE | ACELYRIN, INC. Provides Business Update and Highlights Key.. |
| 09/5/2024 | 14:00 | GLOBE | ACELYRIN, INC. Announces Leadership Transition |
| 29/4/2024 | 22:05 | GLOBE | ACELYRIN, INC. to Report First Quarter 2024 Financial.. |
| 28/3/2024 | 21:05 | GLOBE | ACELYRIN, INC. Reports Full Year 2023 Financial Results and.. |
| 27/3/2024 | 21:01 | GLOBE | Avalo Acquires Anti-IL-1β mAb and Announces Private.. |
| 20/3/2024 | 12:00 | GLOBE | ACELYRIN, INC. Announces Positive Phase 1/2 Proof-of-Concept.. |
| 11/3/2024 | 13:05 | EDGAR2 | Form 8-K - Current report |
Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
